StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences total assets

Total assets on the balance sheet at the end of each period.

Precision BioSciences's total assets was $125.92M at Jun 30, 2026. For fiscal 2025 it was $154.42M, up 13.2% from the year before. The highest annual figure on record is $238.17M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$154.42M+13.2%
FY2024Dec 31, 2024$136.39M-14.6%
FY2023Dec 31, 2023$159.78M-32.9%
FY2022Dec 31, 2022$238.17M+12.6%
FY2021Dec 31, 2021$211.50M+40.9%
FY2020Dec 31, 2020$150.16M-36.2%
FY2019Dec 31, 2019$235.23M+69.7%
FY2018Dec 31, 2018$138.60M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$125.92M+15.6%
Q1 FY2026Mar 31, 2026$143.89M+15.7%
Q4 FY2025Dec 31, 2025$154.42M+13.2%
Q3 FY2025Sep 30, 2025$93.51M-39.0%
Q2 FY2025Jun 30, 2025$108.93M-34.3%
Q1 FY2025Mar 31, 2025$124.41M-32.7%
Q4 FY2024Dec 31, 2024$136.39M-14.6%
Q3 FY2024Sep 30, 2024$153.26M-6.7%
Q2 FY2024Jun 30, 2024$165.80M-8.7%
Q1 FY2024Mar 31, 2024$184.74M-9.7%
Q4 FY2023Dec 31, 2023$159.78M-32.9%
Q3 FY2023Sep 30, 2023$164.34M-39.5%
Q2 FY2023Jun 30, 2023$181.70M-38.9%
Q1 FY2023Mar 31, 2023$204.50M+12.8%
Q4 FY2022Dec 31, 2022$238.17M+12.6%
Q3 FY2022Sep 30, 2022$271.73M+19.6%
Q2 FY2022Jun 30, 2022$297.16M+29.1%
Q1 FY2022Mar 31, 2022$181.35M-30.9%
Q4 FY2021Dec 31, 2021$211.50M+40.9%
Q3 FY2021Sep 30, 2021$227.20M+34.7%
Q2 FY2021Jun 30, 2021$230.11M+24.9%
Q1 FY2021Mar 31, 2021$262.32M+22.5%
Q4 FY2020Dec 31, 2020$150.16M-36.2%
Q3 FY2020Sep 30, 2020$168.69M-35.2%
Q2 FY2020Jun 30, 2020$184.19M-32.3%
Q1 FY2020Mar 31, 2020$214.20M+28.4%
Q4 FY2019Dec 31, 2019$235.23M+69.7%
Q3 FY2019Sep 30, 2019$260.30M–
Q2 FY2019Jun 30, 2019$271.92M–
Q1 FY2019Mar 31, 2019$166.80M–
Q4 FY2018Dec 31, 2018$138.60M–

More Precision BioSciences figures

See a number that looks wrong?